{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:28:09Z","timestamp":1778722089106,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Norwegian Financial Mechanism","award":["2015-2017"],"award-info":[{"award-number":["2015-2017"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.phrs.2016.05.017","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T10:46:43Z","timestamp":1464173203000},"page":"754-759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"PB","title":["Atypical 1,4-dihydropyridine derivatives, an approach to neuroprotection and memory enhancement"],"prefix":"10.1016","volume":"113","author":[{"given":"Vija","family":"Klusa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.05.017_bib0005","first-page":"68","article-title":"Dihydropyridine derivatives as bioprotectors","volume":"26","author":"Duburs","year":"2008","journal-title":"Chem. Today"},{"key":"10.1016\/j.phrs.2016.05.017_bib0010","first-page":"943","article-title":"Influence of calcium channel inhibitors upon the anticonvulsant efficacy of common antiepileptics against pentylenetetrazol-induced convulsions in mice","volume":"29","author":"Czuczwar","year":"1990","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2016.05.017_bib0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0028-3908(01)00200-3","article-title":"L-type Ca2+ channel modulation by dihydropyridines potentiates-\u03ba-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats","volume":"42","author":"Gullapalli","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.05.017_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1358\/dof.1995.020.02.284117","article-title":"Cerebrocrast (IOS-1.1212). neuroprotectant, cognition enhancer","volume":"20","author":"Klusa","year":"1995","journal-title":"Drugs Future"},{"key":"10.1016\/j.phrs.2016.05.017_bib0025","first-page":"75","article-title":"1,4-Dihydropyridines: a multtifunctional Molecule\u2014a review","volume":"3","author":"Swarnalatha","year":"2011","journal-title":"CInt. J. Chem. Tech. Res."},{"key":"10.1016\/j.phrs.2016.05.017_bib0030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cbf.1442","article-title":"Acute effect of antidiabetic 1,4-dihydropyridine compound cerebrocrast on cardiac function and glucose metabolism in the isolated, perfused normal rat heart","volume":"26","author":"Briede","year":"2008","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.phrs.2016.05.017_bib0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1023\/A:1023632419813","article-title":"1,4-Dihydropyridines as calcium channel ligands and privileged structures","volume":"23","author":"Triggle","year":"2003","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2016.05.017_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2007.01.016","article-title":"Calcium channel antagonists: clinical uses-past, present and future","volume":"74","author":"Triggle","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2016.05.017_bib0045","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1021\/jm500263v","article-title":"New 5-unsubstituted dihydropyridines with improved CaV1.3 selectivity as potential neuroprotective agents against ischemic injury","volume":"57","author":"Tenti","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2016.05.017_bib0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2014.01.021","article-title":"JM-20 a novel benzodiazepine-dihydropyridine hybrid molecule, protects mitochondria and prevents ischemic insult-mediated neural cell death in vitro","volume":"726","author":"Nu\u00f1ez-Figueredo","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.05.017_bib0055","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.1016\/S0040-4020(02)00989-4","article-title":"Cyclic amino aciod derivatives","volume":"58","author":"Park","year":"2002","journal-title":"Tetrahedron"},{"key":"10.1016\/j.phrs.2016.05.017_bib0060","first-page":"81","article-title":"Cyclic nootropics: similarity and differences in their memory improving action","volume":"5","author":"Misane","year":"1993","journal-title":"Proc. Latvian Acad. Sci. Sect. B"},{"key":"10.1016\/j.phrs.2016.05.017_bib0065","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/BF00820235","article-title":"The anticonvulsant activity of glutapyrone\u2014a new type of derivative of amino acid-containing 1,4-dihydropyridines","volume":"116","author":"Karpova","year":"1993","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.phrs.2016.05.017_bib0070","first-page":"108","article-title":"The effects of glutapyrone a glutamate-containing 1,4-dihydropyridine compound, on the cardiovascular system, muscle contraction and protein kinase C activation","volume":"50","author":"Klusa","year":"1996","journal-title":"Proc. Latvian. Acad. Sci. Sect. B"},{"key":"10.1016\/j.phrs.2016.05.017_bib0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0924-977X(97)00097-7","article-title":"Atypical neuromodulatory profile of glutapyrone, a representative of a novel \u2018class' of amino acid-containing dipeptide-mimicking 1,4-dihydropyridine (DHP) compounds: in vitro and in vivo studies","volume":"8","author":"Misane","year":"1998","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2016.05.017_bib0080","first-page":"403","article-title":"Alcoholized maternal rat offspring: model for testing of physical and psychoemotional neurodeficit","volume":"1","author":"Klusa","year":"1996","journal-title":"Scand. J. Lab. Animal Sci."},{"issue":"80 Suppl","key":"10.1016\/j.phrs.2016.05.017_bib0085","first-page":"29","article-title":"Taurine and tauropyrone: anti-neurodeficit activity in alcoholised rats","volume":"1","author":"Klu\u0161a","year":"1997","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.phrs.2016.05.017_bib0090","first-page":"174","article-title":"Neuroprotective (oxygen-glucose deprivation model) and neurotrophic effects of different 1,4-dihydropyridine derivatives in cerebellar granule cells","volume":"49","author":"Klimaviciusa","year":"2005","journal-title":"Proc. Latvian. Acad. Sci. Part B"},{"key":"10.1016\/j.phrs.2016.05.017_bib0095","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/978-0-387-33504-9_56","article-title":"Anti-neurotoxic effects of tauropyrone, a taurine analogue","volume":"583","author":"Klusa","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phrs.2016.05.017_bib0100","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.2042-7158.2010.01204.x","article-title":"Comparative study of taurine and tauropyrone: GABA receptor binding, mitochondrial processes and behavior","volume":"63","author":"Dzirkale","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.phrs.2016.05.017_bib0105","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/BF00802832","article-title":"Effects of glutapyrone a new amino acid-containing 1,4-dihydropyridine, on focal penicillin-induced epileptic activity and on bicuculline- or thiosemicarbazide-induced convulsions","volume":"116","author":"Karpova","year":"1993","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.phrs.2016.05.017_bib0110","series-title":"Pharmacology of Novel Centrally and Peripherally Acting Drugs","first-page":"51","article-title":"Stress-protective action of 1,4-dihydropyridines","author":"Muceniece","year":"1991"},{"key":"10.1016\/j.phrs.2016.05.017_bib0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cbi.2008.03.001","volume":"17","author":"Fernandes","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.phrs.2016.05.017_bib0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cbf.1340","article-title":"Distinct effects of atypical 1,4-dihydropyridines on 1-methyl-4-phenylpyridinium-induced toxicity","volume":"25","author":"Klimaviciusa","year":"2007","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.phrs.2016.05.017_bib0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1567-7249(03)00060-6","article-title":"Effects of 1,4-dihydropyridine derivatives (cerebrocrast, gammapyrone, glutapyrone, and diethone) on mitochondrial bioenergetics and oxidative stress: a comparative study","volume":"3","author":"Fernandes","year":"2003","journal-title":"Mitochondrion"},{"key":"10.1016\/j.phrs.2016.05.017_bib0130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1742-7843.2008.00221.x","article-title":"Distinct influence of atypical 1,4-dihydropyridine compounds in azidothymidine-induced neuro- and cardiotoxicity in mice ex vivo","volume":"103","author":"Pupure","year":"2008","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.phrs.2016.05.017_bib0135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-0-387-33504-9_33","article-title":"Neuroprotection by taurine and taurine analogues","volume":"583","author":"Ward","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phrs.2016.05.017_bib0140","first-page":"1185","article-title":"Synthesis and selective vasodilating properties of esters of 2,6-dimethyl-4-(2-difluoromethoxyphenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid","volume":"39","author":"Dubur","year":"1989","journal-title":"Arzneim. Forsch. Drug Res."},{"key":"10.1016\/j.phrs.2016.05.017_bib0145","first-page":"51","article-title":"Structure and activity peculiarities of cerebrocrast (IOS-I. 1212), a novel type of CNS-modulating 1,4-dihydropyridine","volume":"9","author":"Klusa","year":"1992","journal-title":"Proc. Latv. Acad. Sci. Part B"},{"key":"10.1016\/j.phrs.2016.05.017_bib0150","first-page":"66","article-title":"Cerebrocrast-induced normalizing effects on CNS functioning in rats injected with cycloheximide during early postnatal period","volume":"9","author":"Misane","year":"1992","journal-title":"Proc. Latv. Acad. Sci. Part B"},{"key":"10.1016\/j.phrs.2016.05.017_bib0155","first-page":"525","article-title":"Search for stroke protecting agents in endothelin-1-induced ischemic stroke model in rats","volume":"48","author":"Rumaks","year":"2012","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.phrs.2016.05.017_bib0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(02)01262-1","article-title":"Anti-inflammatory effects of cerebrocrast in a model of rat paw edema and on mononuclear THP-1 cells","volume":"441","author":"Klegeris","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.05.017_bib0165","first-page":"156","article-title":"Cerebrocrast (IOS-1212) normalizes disturbances of learning, attention, emotional behaviour and brain biogenic amine levels in prenatally hypoxized rats","volume":"11\/12","author":"Klusa","year":"1995","journal-title":"Proc. Latv. Acad. Sci. Part B"},{"key":"10.1016\/j.phrs.2016.05.017_bib0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/(SICI)1099-0844(199709)15:3<211::AID-CBF743>3.0.CO;2-L","article-title":"Modification of swelling-contraction-aggregation processes in rat muscle mitochondria by the 1,4-dihydropyridines, cerebrocrast and glutapyrone, themselves and in the presence of azidothymidine","volume":"15","author":"Velena","year":"1997","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.phrs.2016.05.017_bib0175","series-title":"Mitochondrial Pharmacology and Toxicology","first-page":"185","article-title":"Cerebrocrast as a neuroprotective, anti-diabetic and mitochondrial bioenergetic effector: a putative mechanism of action","author":"Vicente","year":"2006"},{"key":"10.1016\/j.phrs.2016.05.017_bib0180","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1212\/01.wnl.0000303818.38960.44","article-title":"Use of antihypertensives and the risk of Parkinson disease","volume":"70","author":"Becker","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2016.05.017_bib0185","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ana.21937","article-title":"L-type calcium channel blockers and Parkinson disease in Denmark","volume":"67","author":"Ritz","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2016.05.017_bib0190","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/mds.23191","article-title":"Calcium channel blocker use and risk of Parkinson's disease","volume":"25","author":"Simon","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.phrs.2016.05.017_bib0195","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.bbadis.2011.08.013","article-title":"Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine","volume":"1812","author":"Anekonda","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2016.05.017_bib0200","first-page":"849","article-title":"Influence of some quaternised 1,4-dihydropyridine derivatives on liposomes and erythrocyte membranes","volume":"45","author":"Tirzite","year":"1998","journal-title":"Biochem. Mol. Biol. Int."},{"key":"10.1016\/j.phrs.2016.05.017_bib0205","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.bbamem.2010.05.018","article-title":"Mitochondria-targeted penetrating cations as carriers of hydrophobic anions through lipid membranes","volume":"1798","author":"Rokitskaya","year":"2010","journal-title":"Biochim. Biophys. Acta-Biomembr."},{"key":"10.1016\/j.phrs.2016.05.017_bib0210","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0005-2736(00)00327-8","article-title":"Novel cationic amphiphilic 1,4-dihydropyridine derivatives for DNA delivery","volume":"1509","author":"Hyvonen","year":"2000","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.phrs.2016.05.017_bib0215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.crci.2013.07.003","article-title":"Synthesis and studies of structure-activity relationships of novel 4-pyridinium and\/or 1-propargyl substituted 1,4-dihydropyridine derivatives","volume":"17","author":"Rucins","year":"2014","journal-title":"C.R. Chim."},{"key":"10.1016\/j.phrs.2016.05.017_bib0220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1126\/science.1166305","article-title":"Delivery of a quaternary pyridinium salt across the blood-brain barrier by its dihydropyridine derivative","volume":"190","author":"Bodor","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.phrs.2016.05.017_bib0225","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/1098-1128(200009)20:5<367::AID-MED3>3.0.CO;2-P","article-title":"Targeting drugs to the brain by redox chemical delivery systems","volume":"20","author":"Prokai","year":"2000","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phrs.2016.05.017_bib0230","doi-asserted-by":"crossref","first-page":"e0127686","DOI":"10.1371\/journal.pone.0127686","article-title":"A novel 1 4-dihydropyridine derivative improves spatial learning and memory and modifies brain protein expression in wild type and transgenic APPSweDI mice","volume":"10","author":"Jansone","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.05.017_bib0235","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ceca.2014.02.005","article-title":"Calcium dysregulation, and lithium treatment to forestall Alzheimer's disease\u2014a merging of hypotheses","volume":"55","author":"Wallace","year":"2014","journal-title":"Cell Calcium"},{"key":"10.1016\/j.phrs.2016.05.017_bib0240","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.bbamem.2012.09.018","article-title":"Alternative splicing: functional diversity among voltage-gated calcium channels and behavioral consequences","volume":"1828","author":"Lipscombe","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2016.05.017_bib0245","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/mol.108.049981","article-title":"Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms","volume":"75","author":"Sinnegger-Brauns","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2016.05.017_bib0250","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/npp.2010.53","article-title":"Behavioral and neural analysis of GABA in the acquisition consolidation, reconsolidation, and extinction of fear memory","volume":"35","author":"Makkar","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2016.05.017_bib0255","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/hipo.20837","article-title":"Septohippocampal pathways contribute to system consolidation of a spatial memory: sequential implication of GABAergic and cholinergic neurons","volume":"21","author":"Lecourtier","year":"2011","journal-title":"Hippocampus"},{"key":"10.1016\/j.phrs.2016.05.017_bib0260","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1098\/rstb.2001.0948","article-title":"J. O'Keefe, Memory for events and their spatial context: models and experiments","volume":"356","author":"Burgess","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"10.1016\/j.phrs.2016.05.017_bib0265","doi-asserted-by":"crossref","first-page":"10071","DOI":"10.1073\/pnas.1204606109","article-title":"Loss of functional GABA(A) receptors in the Alzheimer diseased brain","volume":"109","author":"Limon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.05.017_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2014.00167","article-title":"GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease","volume":"8","author":"Nava-Mesa","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.phrs.2016.05.017_bib0275","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrn919","article-title":"Is there more to GABA than synaptic inhibition?","volume":"3","author":"Owens","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2016.05.017_bib0280","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrn.2015.21","article-title":"Mechanisms and functions of GABA co-release","volume":"17","author":"Tritsch","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2016.05.017_bib0285","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1460-9568.2010.07077.x","article-title":"Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats","volume":"31","author":"Soderstorm","year":"2010","journal-title":"Eur. J. Neurosci."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816302316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816302316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T03:39:11Z","timestamp":1718595551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816302316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":57,"alternative-id":["S1043661816302316"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.05.017","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical 1,4-dihydropyridine derivatives, an approach to neuroprotection and memory enhancement","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}